192 related articles for article (PubMed ID: 16921445)
1. [Innovative therapeutic approach to atrial fibrillation: AT1-receptor blocker].
Goette A
Dtsch Med Wochenschr; 2006 Aug; 131(34-35 Suppl 4):S103-7. PubMed ID: 16921445
[No Abstract] [Full Text] [Related]
2. The impact of suppressing the renin-angiotensin system on atrial fibrillation.
Kalus JS; Coleman CI; White CM
J Clin Pharmacol; 2006 Jan; 46(1):21-8. PubMed ID: 16397280
[TBL] [Abstract][Full Text] [Related]
3. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation.
Baker WL; White CM
Conn Med; 2007 Apr; 71(4):205-9. PubMed ID: 17487005
[No Abstract] [Full Text] [Related]
5. [Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system].
Dabrowski R; Szwed H
Kardiol Pol; 2007 Apr; 65(4):440-5. PubMed ID: 17530565
[No Abstract] [Full Text] [Related]
6. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
7. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation].
Doğan A; Akçay S
Anadolu Kardiyol Derg; 2009 Dec; 9(6):505-11. PubMed ID: 19965325
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system inhibitors and atrial fibrillation.
Arbel Y; Glikson M
Isr Med Assoc J; 2005 Jun; 7(6):388-91. PubMed ID: 15984384
[No Abstract] [Full Text] [Related]
9. Role of renin-angiotensin system inhibitors in atrial fibrillation.
Disertori M; Latini R; Maggioni AP
J Cardiovasc Med (Hagerstown); 2011 May; 12(5):374; author reply 375. PubMed ID: 21451337
[No Abstract] [Full Text] [Related]
10. Atrial fibrillation and renin-angiotensin system.
Serra JL; Bendersky M
Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials, the renin angiotensin system and atrial fibrillation.
Birnie DH; Gollob M; Healey JS
Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
[TBL] [Abstract][Full Text] [Related]
12. Valsartan and recurrent atrial fibrillation.
Tomoda H
N Engl J Med; 2009 Jul; 361(5):532-3; author reply 533. PubMed ID: 19645082
[No Abstract] [Full Text] [Related]
13. Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence.
Disertori M; Latini R; Maggioni AP; Delise P; Di Pasquale G; Franzosi MG; Staszewsky L; Tognoni G;
J Cardiovasc Med (Hagerstown); 2006 Jan; 7(1):29-38. PubMed ID: 16645357
[TBL] [Abstract][Full Text] [Related]
14. [Non-antiarrhythmic pharmacological treatment of atrial fibrillation: focus on drugs acting on the renin-angiotensin system].
Durin O; Pedrinazzi C; Inama G
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):5S-10S. PubMed ID: 19195299
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.
Huang G; Xu JB; Liu JX; He Y; Nie XL; Li Q; Hu YM; Zhao SQ; Wang M; Zhang WY; Liu XR; Wu T; Arkin A; Zhang TJ
Eur J Clin Invest; 2011 Jul; 41(7):719-33. PubMed ID: 21250983
[TBL] [Abstract][Full Text] [Related]
16. Direct pro-arrhythmogenic effects of angiotensin II can be suppressed by AT1 receptor blockade in human atrial myocardium.
von Lewinski D; Kockskämper J; Rübertus SU; Zhu D; Schmitto JD; Schöndube FA; Hasenfuss G; Pieske B
Eur J Heart Fail; 2008 Dec; 10(12):1172-6. PubMed ID: 18993115
[TBL] [Abstract][Full Text] [Related]
17. [Atrial fibrillation and renin-angiotensin system].
Yamashita T
Nihon Rinsho; 2007 Mar; 65(3):569-74. PubMed ID: 17354577
[TBL] [Abstract][Full Text] [Related]
18. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
[TBL] [Abstract][Full Text] [Related]
19. [Non-channel drugs to prevent atrial fibrillation].
Fazekas T; Liszkai G
Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
[TBL] [Abstract][Full Text] [Related]
20. Focus on renin-angiotensin system modulation and atrial fibrillation control after GISSI AF results.
Durin O; Pedrinazzi C; Inama G
J Cardiovasc Med (Hagerstown); 2010 Dec; 11(12):912-8. PubMed ID: 20729747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
